MARIA BENETOS: Open Payments
NPI 1831303718 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,033 in 83 payments from 13 companies in 2025. Trend: 2023 $627 · 2024 $1,099 · 2025 $2,033
Food & beverage: $2,033
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $362 |
| Otsuka America Pharmaceutical, Inc. | 17 | $313 |
| E.R. Squibb & Sons, L.L.C. | 9 | $301 |
| Alkermes, Inc. | 8 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $251 |
| Lundbeck LLC | 11 | $220 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $56 |
| Corium, LLC | 2 | $45 |
Products named: REXULTI, Auvelity, COBENFY, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
